Dr. Sylvain Benzakin
Chairs and coordinates the committee’s work: setting agendas, running meetings and acting as the main point of contact with the company. The chair is elected by the members by secret ballot, for a two-year term renewable once.
Our content is produced with artificial intelligence — and that is precisely why twelve independent doctors and experts govern what it is allowed to say. They define the rules it applies, validate the medical accuracy of our content and monitor its behavior to reduce the risk of error as far as possible. They serve under a written, signed charter that sets out their missions, their independence and the limits of what the tool may assert.
Committee established since September 2025 · Charter version 2, February 2026
The charter deliberately separates the committee’s responsibilities into two pillars, to ensure governance that meets the requirements of the EU AI Act: what belongs to science on one side, what belongs to controlling the AI on the other.
Creating, validating and continuously updating the expert rules — the deterministic logic that frames the artificial intelligence and bounds what it can assert.
Ongoing monitoring of how the AI behaves: algorithmic bias, the risk of hallucinations and validation of model explainability.
Set out in Article 1.2 of the charter, they cover content validation, AI oversight and regulatory compliance.
The committee spans twelve specialties: ENT, internal medicine and nephrology, pediatric oncology, endocrinology, critical care and infectious diseases, cardiology, dental surgery, laboratory medicine, geriatrics, gynecology, general practice and child psychiatry. Every member has at least five years in practice and has signed the committee charter. Every medical article we publish is reviewed and validated by one of them.
Chairs and coordinates the committee’s work: setting agendas, running meetings and acting as the main point of contact with the company. The chair is elected by the members by secret ballot, for a two-year term renewable once.
The co-founders attend meetings without voting rights. Three of them sit as observers and a fourth acts as administrative secretary. They take part in neither the deliberations nor the votes, speak only when the committee invites them to, and are bound by the same confidentiality and conflict-of-interest obligations as the members.
The committee meets roughly once a month. Each meeting has an agenda circulated in advance and a written record.
The committee brings together independent experts. Its opinions are advisory and inform the company’s decisions. The charter provides for 6 to 15 members; there are currently 12.
Every member declares any potential conflict on appointment and at each meeting. Where a conflict is established, the member abstains from the related discussions and decisions.
The committee formally refuses to validate any rule or wording amounting to a diagnosis, a prognosis or a personalized treatment recommendation.
Every member signs a confidentiality agreement and accesses only pseudonymized or anonymized data, within secure environments.
An initial two-year term, renewable by decision of the committee, to balance continuity of expertise with the renewal of skills.
Decisions are made by consensus; failing that, by simple majority. Quorum is half the members plus one. An extraordinary meeting can be convened within 48 hours.
The committee designs and validates interpretation rules strictly limited to health literacy and science communication.
To preserve AI DiagMe’s status as a non-medical device, it refuses to create, validate or endorse any expert rule, feature or AI-generated wording that would amount to a medical diagnosis, a prediction of disease progression or a personalized treatment recommendation.
Article 14 of the charter gives the committee a specific role in how the models themselves operate.
The committee oversees the assessment of bias in the algorithms and training data, and ensures it is corrected.
Every AI model update must be validated by the committee before deployment, to confirm its scientific and ethical compliance.
The committee sets the criteria for assessing the quality of the data used by the models.
Algorithmic changes follow a written process including testing and review phases.
Our governance is written down and verifiable. Both documents are made available to patients, partners, healthcare professionals and authorities on request.
The reference document, signed by every member: objectives and missions, impartiality and conflicts of interest, scope limits, membership, operation, ethical principles, confidentiality and AI-specific provisions. Version 2 — February 2026, reviewed at least every two years.
Download the charter (PDF)Sent by email on request.
An annual summary of the committee’s work: the main opinions issued, the recommendations made and the action taken. A public version is made available to stakeholders, while protecting sensitive information.
Download the report (PDF)Sent by email on request.
The charter provides for a committee of six to fifteen members. We welcome new expertise, particularly in specialties that are still under-represented.
Write to us with your specialty, your medical registration number and what motivates your application. We reply to every candidate.
Submit my applicationFor any question about the committee’s work, the charter or our validation rules: contact@aidiagme.com.